Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Giuffrida A et al. |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. |
1999 |
Nat. Neurosci. |
pmid:10204543
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Di Marzo V et al. |
Trick or treat from food endocannabinoids? |
1998 |
Nature |
pmid:9872309
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|
Feliszek M et al. |
Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. |
2016 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:26984820
|
Schulte K et al. |
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. |
2012 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:22215206
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
Ilayan E et al. |
Do cannabinoids exhibit a tyramine-like effect? |
2013 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:23900610
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Fernández-Suárez D et al. |
Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. |
2014 |
Neurobiol. Aging |
pmid:24973119
|
Arevalo-Martin A et al. |
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. |
2010 |
Neurobiol. Dis. |
pmid:20156559
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Vázquez C et al. |
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies. |
2015 |
Neurobiol. Dis. |
pmid:25917763
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|